ALISON CHANG, MD
Hematology & Oncology Physician · PALO ALTO, CA
Individual Active NPI 1205253465
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 905 | 231,918 | $15,169,751 | $5,905,191 | $4,688,333 |
| 2023 | 805 | 169,023 | $11,296,966 | $4,263,137 | $3,384,973 |
| 2022 | 749 | 193,930 | $10,324,211 | $3,968,918 | $3,156,015 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J3262 | Injection, tocilizumab, 1 mg | 21,368 | $6 | $5 |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 15,300 | $22 | $17 |
| J9271 | Injection, pembrolizumab, 1 mg | 15,200 | $56 | $44 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 7,920 | $49 | $39 |
| J1453 | Injection, fosaprepitant, 1 mg | 6,000 | $0 | $0 |
| J3032 | Injection, eptinezumab-jjmr, 1 mg | 5,500 | $18 | $14 |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 5,350 | $12 | $9 |
| J1459 | Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg | 5,100 | $48 | $38 |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 4,830 | $11 | $9 |
| J9030 | Bcg live intravesical instillation, 1 mg | 2,600 | $3 | $2 |
| J0897 | Injection, denosumab, 1 mg | 2,100 | $26 | $21 |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 2,040 | $20 | $16 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | A139702 | CA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in California
- NPI 1023698388
- NPI 1063652386
- NPI 1962650895
- NPI 1891182465
- NPI 1992182638
- NPI 1457538449
- NPI 1235207911
- NPI 1720200363
See all Hematology & Oncology Physician providers in California →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.